China Diagnostic Electrocardiograph/ECG Market (2025-2030)
The China Diagnostic Electrocardiograph/ECG Market was valued at $185.7 Million in 2025 and projected to reach to $378.6 Million by 2030, representing a compound annual growth rate of 10.7%. China's diagnostic electrocardiograph market is positioned for substantial growth, expanding from USD 185.7 million in 2025 to USD 378.6 million by 2030.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
China Diagnostic Electrocardiograph/ECG Market Trends and Insights
- This represents a compound annual growth rate of 10.7%, significantly outpacing global market growth of 7.4%.
- China's rapid urbanization, aging population, and increased healthcare spending are driving demand for advanced cardiac diagnostic equipment across hospitals, clinics, and diagnostic centers. The Chinese ECG market benefits from government initiatives promoting cardiovascular disease screening and early detection programs.
- China's healthcare infrastructure modernization and rising prevalence of cardiac conditions among its population are accelerating adoption of both traditional and portable ECG devices.
- Between 2025 and 2030, China is expected to emerge as a critical growth engine within the Asia Pacific region, with expanding domestic manufacturing capabilities and increasing integration of digital health technologies into diagnostic workflows. Key market drivers in China include enhanced reimbursement policies, growing awareness of preventive cardiology, and substantial investments in medical device innovation.
- China's position as both a major manufacturer and consumer of ECG equipment positions it as a strategic market for global and regional players seeking to capitalize on sustained healthcare sector growth..
Key Market Statistics
- CAGR (2025-2030) 10.7% CAGR
- Market Size, 2025 ~USD 185.7 Million
- Forecast, 2030 ~USD 378.6 Million
- Country China
China Diagnostic Electrocardiograph/ECG Market Overview
Rapid Market Expansion :
China's diagnostic ECG market is growing at 10.7% CAGR, significantly outpacing the global rate of 7.4%, driven by increasing cardiac disease prevalence and healthcare modernization initiatives across urban and rural regions.
Aging Population Dynamics :
With China's rapidly aging demographic, cardiovascular diseases are becoming increasingly prevalent. This demographic shift is creating sustained demand for diagnostic ECG equipment in hospitals, clinics, and primary care facilities nationwide.
Healthcare Infrastructure Investment :
Government initiatives to strengthen healthcare infrastructure and increase accessibility to diagnostic services in tier-2 and tier-3 cities are accelerating ECG device adoption and creating new market opportunities.
Rising Healthcare Expenditure :
Increased healthcare spending by both government and private sectors, coupled with growing patient awareness of preventive cardiac care, is fueling demand for advanced diagnostic electrocardiograph systems across China.
China Diagnostic Electrocardiograph/ECG Market Dynamics
- This trajectory reflects structural economic factors including urbanization, rising disposable incomes, and government healthcare reforms prioritizing cardiac disease detection and prevention.
- The market benefits from both increased hospital capacity and growing adoption in primary care settings. Key growth drivers include technological advancement in portable and digital ECG systems, integration with telemedicine platforms, and regulatory support for medical device innovation.
- As China continues to upgrade its healthcare infrastructure and address the cardiovascular health crisis associated with its aging population, the ECG market will experience sustained expansion, attracting both domestic manufacturers and international players seeking to capture this high-growth opportunity..
Related Ecosystem
Cardiovascular Devices
- External Defibrillators
- Implantable Cardioverter Defibrillators
- Pulse Oximeters
- Robotic Systems
- 3-Lead ECG Leadwires
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- CONMED Corporation
- KONINKLIJKE PHILIPS N.V.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- China's ECG market will nearly double from USD 185.7M (2025) to USD 378.6M (2030), driven by 10.7% CAGR growth.
- China's aging population and rising cardiovascular disease prevalence are primary catalysts for increased ECG device adoption.
- Government healthcare initiatives and improved reimbursement policies in China are accelerating market penetration across tier-2 and tier-3 cities.
- China's domestic manufacturing ecosystem and digital health integration position it as the fastest-growing ECG market in Asia Pacific.
Diagnostic Electrocardiograph/ECG Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SINGLE-LEAD ECG DEVICES (Lead Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 7.4% from 2025 to 2030 |
| Largest Segment | DEVICES (Product) |
| Market Size Base Year (Billions) | ~USD 9.21 (2025) |
| Revenue Forecast (Billions) | ~USD 13.16 (2030) |
| Segments Covered | Product, Type, Lead Type, Deployment/Connectivity, End User, Device Type, Connectivity/Deployment |
China Diagnostic Electrocardiograph/ECG Market Report Segmentation
7 segment dimensions are covered across the global market.
By Product
- Devices
- Software & Services
By Type
- Event Monitors
- Holter Monitors
- Implantable
- Implantable Loop Recorders
- Mobile Cardiac Telemetry Devices
- Portable
- Resting Ecg Devices
- Smart Ecg Devices
- Stress Ecg Devices
- Wearable
By Lead Type
- 12-Lead Ecg Devices
- 3-Lead Ecg Devices
- 5-Lead Ecg Devices
- 6-Lead Ecg Devices
- Other Ecg Lead Devices
- Single-Lead Ecg Devices
By Deployment/Connectivity
- Cloud-Based Ecg Devices
- Pc-Based Ecg Devices
- Standalone Ecg Devices
By End User
- Ambulatory Surgical Centers
- Cardiac Centers
- Home Care Settings
- Hospitals
- Other End Users
- Primary Care Centers
- Urgent Care Settings
By Device Type
- Event Monitors
- Holter Monitors
- Implantable Loop Recorders
- Mobile Cardiac Telemetry Devices
- Resting Ecg Devices
- Smart Ecg Devices
- Stress Ecg Devices
By Connectivity/Deployment
- Cloud-Based Ecg Devices
- Pc-Based Ecg Devices
- Standalone Ecg Devices
CHINA: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032
| Segment | 2023 | 2024 | 2025 | 2029 | 2030 | 2031 | 2032 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|
| AMBULATORY SURGICAL CENTERS | 13.67 | 14.81 | 16.07 | 22.49 | 24.54 | 26.89 | 29.43 | 9 |
| CARDIAC CENTERS | 76.91 | 85.19 | 94.55 | 144.62 | 161.37 | 180.73 | 202.23 | 11.5 |
| HOME CARE SETTINGS | 22.86 | 25.37 | 28.21 | 43.51 | 48.65 | 54.6 | 61.22 | 11.7 |
| HOSPITALS | 226.48 | 248.73 | 273.68 | 404.38 | 447.32 | 496.65 | 550.92 | 10.5 |
| OTHER END USERS | 19.51 | 21.01 | 22.66 | 30.95 | 33.56 | 36.54 | 39.74 | 8.4 |
| PRIMARY CARE CENTERS | 74.53 | 82.07 | 90.53 | 135.17 | 149.92 | 166.88 | 185.6 | 10.8 |
| URGENT CARE SETTINGS | 19.96 | 21.94 | 24.17 | 35.87 | 39.73 | 44.17 | 49.06 | 10.6 |
| TOTAL | 453.91 | 499.11 | 549.87 | 816.98 | 905.08 | 1006.45 | 1118.19 | 10.7 |
Target Audience
- Medical Device Manufacturers : ECG equipment producers need China-specific market data to develop localized product strategies, identify distribution channels, understand competitive positioning, and forecast revenue potential in this rapidly expanding market.
- Healthcare Investors & PE Firms : Investment professionals require validated market sizing and growth projections for China to evaluate portfolio opportunities, assess risk-return profiles, and make informed capital allocation decisions in the cardiac diagnostics sector.
- Hospital & Healthcare Facility Operators : Healthcare administrators need market intelligence to benchmark equipment procurement costs, evaluate supplier options, plan capital expenditure budgets, and optimize diagnostic service offerings across their facilities.
- Market Entry & Strategy Consultants : Consulting firms advising clients on China market expansion require detailed market analysis to develop go-to-market strategies, competitive assessments, regulatory guidance, and business case development for ECG device companies.
- Government & Policy Organizations : Healthcare policy makers and government agencies need market data to inform healthcare infrastructure planning, medical device procurement policies, and strategic initiatives supporting cardiac disease prevention and diagnosis in China.
Key Companies in the China Diagnostic Electrocardiograph/ECG Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KINDRED HEALTHCARE INC. | United States | Private Company | Long-term acute care hospitals (LTACH) – high-intensity injectable and infusion utilization,Inpatient rehabilitation facilities – chronic disease and post-surgical medication management,Contract rehabilitation and ancillary services – distributed outpatient and SNF-based demand, |
| CONMED CORPORATION | United States | Public Company | Orthopedic sports medicine and powered instruments,General surgery (AirSeal, Buffalo Filter, endomechanical, electrosurgery),Endoscopic technologies and patient monitoring, |
| ENERSYS | United States | Public Company | Network & Infrastructure Solutions,Industrial Mobility Solutions,Precision Power Solutions, |
| AT&S | Canada | Public Company | Turnkey automated manufacturing and assembly systems,Pre- and post-automation lifecycle services,Software and digital solutions, |
| KONINKLIJKE PHILIPS N.V. | Netherlands | Public Company | Diagnosis & Treatment (Imaging and Image-Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep & Respiratory Care),Personal Health, |
| GE HEALTHCARE | United States | Public Company | Imaging,Advanced Visualization Solutions (Ultrasound and Interventional),Patient Care Solutions, |
| MEDTRONIC | Ireland | Public Company | Cardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Robotics & AI Surgical Video), |
| BOSTON SCIENTIFIC CORPORATION | United States | Public Company | Cardiovascular (Interventional Cardiology, Peripheral Interventions, Structural Heart, CRM),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health, |
| ABBOTT LABORATORIES | United States | Public Company | Medical Devices (cardiovascular, diabetes care, neuromodulation, vascular, structural heart),Diagnostic Products (core lab, molecular, point-of-care, rapid and cardiometabolic testing),Nutritional Products (pediatric, adult, and infant formula), |
| FUKUDA DENSHI | Japan | Public Company | Resting ECG and stress test systems,Patient monitoring systems (central and bedside, telemetry),Vascular screening systems and data management software, |
| SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. | China | Public Company | Patient Monitoring & Life Support (monitors, ventilators, anesthesia, defibrillation, infusion),Medical Imaging (ultrasound, radiology, endoscope camera systems),In Vitro Diagnostics (CLIA, chemistry, hematology, lab solutions), |
| NIHON KOHDEN CORPORATION | Japan | Public Company | Patient monitors & clinical information systems,Physiological measuring & neuro-diagnostics,Defibrillators, AEDs & resuscitation devices, |
| OSI SYSTEMS, INC. | United States | Public Company | Security (Rapiscan, S2, radiation and trace detection),Healthcare (Spacelabs patient and remote monitoring),Optoelectronics and Manufacturing (devices, EMS, LCDs), |
| BITTIUM | Finland | Public Company | Defense & Security (Tough Mobile, Tactical Wireless IP Network, Tough SDR/VoIP, Secure Suite, lifecycle services),Medical (Faros, OmegaSnap, Cardiac Navigator, MedicalSuite, Respiro, BrainStatus, NeurOne),Engineering Services (product design, wireless and IoT development, testing, certification, ramp-up), |
| IRHYTHM TECHNOLOGIES, INC. | United States | Public Company | Zio XT System – long-term continuous ECG monitoring,Zio AT System – mobile cardiac telemetry,Zio Monitor System – short-term and other monitoring services, |
| LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. | China | Public Company | Cardiovascular interventional devices,In vitro diagnostics and imaging,Pharmaceutical products, |
KINDRED HEALTHCARE INC.
Kindred Healthcare Inc. is a private healthcare company founded in 1985 and headquartered in the United States. With 64,200 employees, it operates as a major provider of healthcare services across the country.
CONMED CORPORATION
ConMed Corporation is a publicly traded medical technology company founded in 1970 and based in the United States. The company employs 3,900 people and specializes in surgical and patient monitoring equipment.
ENERSYS
EnerSys is a publicly traded energy storage and power solutions company founded in 1991 and headquartered in the United States. With 9,682 employees, it serves industrial and commercial markets globally.
AT&S
AT&S is a Canadian public company founded in 1978 with 7,000 employees. The company operates in the technology and manufacturing sectors.
KONINKLIJKE PHILIPS N.V.
Koninklijke Philips N.V. is a publicly traded Dutch multinational company founded in 1891 with 63,670 employees. The company operates across healthcare, consumer lifestyle, and lighting sectors globally.
GE HEALTHCARE
GE Healthcare is a publicly traded healthcare technology company founded in 2022 and headquartered in the United States. With 54,000 employees, it provides medical imaging, diagnostics, and healthcare IT solutions.
MEDTRONIC
Medtronic is a publicly traded medical technology company founded in 1949 and headquartered in Ireland. With 95,000 employees worldwide, it develops and manufactures medical devices and therapies.
BOSTON SCIENTIFIC CORPORATION
Boston Scientific Corporation is a publicly traded medical device company founded in 1979 and based in the United States. With 59,000 employees, it develops and markets medical devices for various therapeutic areas.
ABBOTT LABORATORIES
Abbott Laboratories is a publicly traded healthcare company founded in 1888 and headquartered in the United States. With 115,000 employees, it operates across diagnostics, medical devices, nutrition, and pharmaceuticals.
FUKUDA DENSHI
Fukuda Denshi is a publicly traded Japanese medical device company founded in 1939 with 3,497 employees. The company specializes in diagnostic and monitoring equipment for healthcare applications.
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is a publicly traded Chinese medical device manufacturer founded in 1991 with 21,288 employees. The company develops and produces diagnostic and monitoring equipment globally.
NIHON KOHDEN CORPORATION
Nihon Kohden Corporation is a publicly traded Japanese medical device company founded in 1951 with 6,116 employees. The company manufactures patient monitoring and diagnostic equipment for healthcare facilities.
OSI SYSTEMS, INC.
OSI Systems, Inc. is a publicly traded technology company founded in 1987 and based in the United States with 7,337 employees. The company provides security and healthcare technology solutions.
BITTIUM
Bittium is a publicly traded Finnish technology company founded in 1985 with 528 employees. The company specializes in wireless communications and healthcare technology solutions.
IRHYTHM TECHNOLOGIES, INC.
iRhythm Technologies, Inc. is a publicly traded medical device company founded in 2006 and headquartered in the United States. With 2,400 employees, it develops digital health and cardiac monitoring solutions.
LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
Lepu Medical Technology (Beijing) Co., Ltd. is a Chinese medical device company founded in 1999 with 8,689 employees. The company manufactures and distributes cardiovascular and other medical devices.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation for China (USD 185.7M in 2025) and verified 5-year forecast (USD 378.6M by 2030) to support investment decisions, business planning, and competitive positioning in this high-growth market.
- Competitive Landscape Intelligence : Understand China-specific market dynamics, local competitor strategies, and regulatory environment to identify market entry opportunities, partnership potential, and differentiation strategies for ECG device manufacturers.
- Demographic & Healthcare Trends : Access insights into China's aging population, urbanization patterns, and government healthcare initiatives driving ECG demand to align product development, marketing, and distribution strategies with local market needs.
- Regional Growth Opportunity Assessment : Evaluate China's 10.7% CAGR against global 7.4% growth to prioritize resource allocation, identify tier-2/tier-3 city expansion opportunities, and benchmark performance against international markets.
- Strategic Decision Support : Leverage comprehensive China market data for M&A evaluation, partnership negotiations, pricing strategy development, and long-term business planning in Asia's largest healthcare market.
Frequently asked questions
What is the current size of China's ECG market in 2025?
China's diagnostic electrocardiograph market is valued at USD 185.7 million in 2025, representing significant growth potential within the Asia Pacific region.
What is the projected market size for China's ECG market by 2030?
China's ECG market is forecast to reach USD 378.6 million by 2030, more than doubling its 2025 valuation.
What is the CAGR for China's ECG market from 2025 to 2030?
China's ECG market is expected to grow at a compound annual growth rate of 10.7%, outpacing the global average of 7.4%.
What factors are driving growth in China's ECG market?
Key drivers include China's aging population, rising cardiovascular disease prevalence, government healthcare initiatives, improved reimbursement policies, and healthcare infrastructure modernization.
How does China's ECG market compare to global growth rates?
China's 10.7% CAGR significantly exceeds the global ECG market CAGR of 7.4%, making China a critical growth engine for the industry.
RESEARCH METHODOLOGY
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, SEC filings of companies and publications from government sources[such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), European Federation of Pharmaceutical Industries and Associations (EFPIA), American Journal of Drug Delivery and Therapeutics, International Diabetes Federation (IDF), American Association of Diabetes Educators (AADE, Asian Association for the Study of Diabetes (AASD) and Parenteral Drug Association (PDA) were referred to identify and collect information for the global diagnostic electrocardiograph/ECG market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends, to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various companies and organizations in the diagnostic ECG market. The primary sources from the demand side include hospitals & clinics and home care settings. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.
A breakdown of the primary respondents is provided below:
Note 1: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 2: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global diagnostic ECG market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was made for the major players (who contribute at least 70–75% of the market share at the global level). Also, the diagnostic ECG market was split into various segments and sub-segments based on:
- List of major players operating in the diagnostic ECG market at the regional and/or country level
- Product mapping of various diagnostic ECG manufacturers at the regional and/or country level
- Mapping of annual revenue generated by listed major players from diagnostic ECG products (or the nearest reported business unit/product category)
- Revenue mapping of major players to cover at least 70–75% of the global market share as of 2024
- Extrapolation of the revenue mapping of the listed major players to derive the global diagnostic ECG market value of the respective segments/subsegments
- Summation of the market value of all segments/subsegments to arrive at the global diagnostic ECG market
Market Size Estimation (Bottom-up and Top-down Approach)
Data Triangulation
After arriving at the overall size of the global diagnostic ECG market through the methodology mentioned above, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.
Market Definition
Diagnostic ECG devices detect electrical signals associated with cardiac activities to produce a graphic record of the time versus voltage. These ECG devices are equipped with software that analyses the ECG graph to determine the heart rhythm. Various types of ECG devices—holter monitors, resting ECG devices, stress ECG devices, implantable loop recorders (ILRs), event monitors, mobile cardiac telemetry (MCT) devices, and smart ECG monitors—are used by healthcare professionals to monitor and diagnose cardiac conditions.
Stakeholders
- Manufacturers of diagnostic ECG devices
- Distributors of diagnostic ECG devices
- Hospitals, clinics, and cardiac centers
- Ambulatory surgery centers
- Non-government organizations
- Government regulatory authorities
- Contract manufacturers & third-party suppliers
- Research laboratories & academic institutes
- Clinical research organizations (CROs)
- Government & non-governmental regulatory authorities
- Market research & consulting firms
Report Objectives
- To define, measure, and describe the global diagnostic ECG market by product, lead type, type, deployment/ connectivity, end user, and region
- To provide detailed information about the significant factors influencing the diagnostic ECG market growth (drivers, restraints, challenges, and opportunities)
- To strategically analyze the regulatory, pricing, value chain, supply chain, ecosystem, technology, Porter’s Five Forces, and patent analysis
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of market segments in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To strategically analyze the market structure, profile the key players in the global diagnostic ECG market, and comprehensively analyze their core competencies
- To track and analyze company developments such as acquisitions, partnerships, expansions, and product launches & approvals in the diagnostic ECG market
- To track and analyze competitive developments such as mergers & acquisitions, product developments, partnerships, agreements, collaborations, and expansions in the global diagnostic ECG market
Get the Full Diagnostic Electrocardiograph/ECG Market Report
Full forecast, segment splits, and company analysis for all Diagnostic Electrocardiograph/ECG Market.
- US Diagnostic Electrocardiograph/ECG Market
- Canada Diagnostic Electrocardiograph/ECG Market
- Germany Diagnostic Electrocardiograph/ECG Market
- France Diagnostic Electrocardiograph/ECG Market
- UK Diagnostic Electrocardiograph/ECG Market
- Italy Diagnostic Electrocardiograph/ECG Market
- Spain Diagnostic Electrocardiograph/ECG Market
- Japan Diagnostic Electrocardiograph/ECG Market
- India Diagnostic Electrocardiograph/ECG Market
- Australia Diagnostic Electrocardiograph/ECG Market
- South Korea Diagnostic Electrocardiograph/ECG Market
- Malaysia Diagnostic Electrocardiograph/ECG Market
- Thailand Diagnostic Electrocardiograph/ECG Market
- Indonesia Diagnostic Electrocardiograph/ECG Market
- Brazil Diagnostic Electrocardiograph/ECG Market
- Mexico Diagnostic Electrocardiograph/ECG Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
